Close menu




May 28th, 2021 | 10:14 CEST

wallstreet:online, flatexDEGIRO, Commerzbank - If you look closely...

  • Investments
Photo credits: pixabay.com

A positive stock market environment, low-interest rates and stock trading at zero cost are the reasons that have sent the prices of stockbrokers and brokers from all-time high to all-time high in recent months. Intermittent breathers are healthy for the peakers. The latest round of capital in unlisted broker Trade Republic, with a valuation of more than EUR 4 billion, demonstrates the potential investors have for new fee models and an active investor base. The following three stocks are far from exhausted, in our opinion.

time to read: 3 minutes | Author: Carsten Mainitz
ISIN: DE000A2GS609 , DE000FTG1111 , DE000CBK1001

Table of contents:


    WALLSTREET:ONLINE AG - Share increase as a share price booster

    The Company's past is impressive. But what is happening right now, and where the Company wants to go, even more so. wallstreet:online AG has undoubtedly established itself as a force to be reckoned with in the German-speaking market for financial portals. With the launch of Smartbroker at the end of 2019, a new chapter has been opened. The highly scalable and dynamically growing transaction business will soon eclipse the established core business of advertising, and the proper course has been set for this. The combination of high-reach portals and product innovations makes it possible to expand quickly in the relevant market.

    Smartbroker is a so-called neo broker. Neo brokers enable customers to trade very favorably, sometimes even without any costs. How can this work? Quite simply - someone else pays; these are platforms like gettex or brokers like Lang & Schwarz, who pay a fee. Smartbroker's competitors include Trade Republic, justTrade and Gratisbroker. However, Smartbroker differentiates itself once again by offering low terms and additionally a wide range of products.

    Smartbroker is operated by the subsidiary wallstreet:online capital AG, in which the Berlin-based Company has held a stake of around 73% to date. Now wallstreet:online announced its intention to increase its share in wallstreet:online capital to more than 95%. To dovetail growth more closely, CEO Matthias Hach is also taking over the subsidiary's board position. Long-time board member Thomas Soltau will remain on board as a co-board member. The Group has already significantly expanded the Executive Board in the last few months, creating the necessary rapid and successful expansion structures.

    But what does all this mean for the share? Well, Smartbroker aims to have a customer base of 200,000 investors by the end of the year. The mid-term target is about double that. We think that is way too low. Currently, Smartbroker has more than EUR 5 billion in customer assets. At the current share price of EUR 26.50, the Group is valued at almost EUR 400 million - including the profitable core business of advertising, of course. Considering that competitor Trade Republic, with a customer base of "over 1 million" and customer funds of more than EUR 6 billion, was recently granted a valuation of over EUR 4 billion, the savvy investor might conclude that wallstreet:online's stock is far, far too cheap. Score!

    flatexDEGIRO AG - That is quite an announcement

    This Tuesday, Europe's largest online broker for private customers published its new 5-year vision. Just last year, flatex took over competitor DEGIRO. With this lineup, the Company trusts itself to serve 7 to 8 million brokerage customers in 2026 and process 250 to 350 million transactions per year. This means that the Company aims to acquire an average of more than 1 million customers per year in the medium term! At first glance, this figure may sound a little too ambitious, but one should bear in mind that flatexDEGIRO is active in 18 European countries. Those countries on which the Group mainly focuses are those that have enormous catch-up potential in terms of online brokerage.

    The stock market is celebrating this outlook. The analysts were enthusiastic and surpassed themselves by raising their price targets. The SDAX title is currently trading at around EUR 105, within sight of the all-time high of EUR 114 reached at the end of April. The stock market value is presently EUR 2.9 billion. If analysts are to be believed, the current level offers a phenomenal buying opportunity. The most recent assessments by Berenberg and Warburg give price targets of EUR 165 and EUR 170, respectively. That means upside potential of around 60%!

    COMMERZBANK AG - Into the black with a structured plan

    In the middle of the month, Commerzbank invited its long-suffering shareholders to the Corona-compliant virtual AGM. After many years of frustration, the management's words seem to give courage and one or the other development. One thing is sure: in the course of fundamental restructuring, the red pencil is being applied to many points. By the end of 2024, the number of full-time positions across the Group will fall from around 39,500 to 32,000. The store network in Germany will be almost halved to 450 locations. In the current year, 200 stores are already to be closed. In addition, the Group is giving up 15 sites abroad.

    By 2024, the bank aims to save around 20% of its previous costs with all these measures and thus become profitable and competitive again. For those who need something tangible in the present and dreams of the future, we recommend studying the Q1 figures. After all, things went much better for the institute in the first quarter than market participants had expected. Instead of analysts' triple-digit million loss forecast, the Company reported a profit of EUR 133 million. Investors should keep an eye on the stock. The share is not expensive, especially if further successes of the restructuring become visible.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Carsten Mainitz

    The native Rhineland-Palatinate has been a passionate market participant for more than 25 years. After studying business administration in Mannheim, he worked as a journalist, in equity sales and many years in equity research.

    About the author



    Related comments:

    Commented by Juliane Zielonka on December 1st, 2022 | 10:44 CET

    Aspermont, Twitter, Apple - Strong numbers, strong visions and marketplace power

    • Digitization
    • Commodities
    • Investments

    The Australian media company for the commodities industry has presented its latest figures. The results are impressive, with total revenue up 17% YOY, among other things. This industry pioneer illustrates just how valuable access to high-quality information can be. Perhaps soon to disappear from the scene is Elon Musk's Twitter: Find out how strong its dependence on the App Store giant is and what impact Apple fees may have on its revenue model here.

    Read

    Commented by Fabian Lorenz on November 30th, 2022 | 13:31 CET

    Biotech stocks in focus: Morphosys, Evotec, Bayer, BioNxt Solutions

    • Biotechnology
    • Cancer
    • Investments

    Biotech stocks have struggled in 2022. In Germany, BioNTech has overtaken the previous heavyweights Morphosys and Evotec in record time. Morphosys shocked investors with data on its Alzheimer's hope. Analysts lowered their thumbs, and short-sellers discovered the stock for themselves. Evotec has been quiet this year. Analysts think the valuation is attractive, but meeting earnings guidance in the current year is not a given. BioNxt shares have jumped recently, and if the positive newsflow continues into 2023, a re-rating is possible. At Bayer, the pharmaceuticals division is also developing positively. Conclusion: investors should position themselves for the biotech year 2023.

    Read

    Commented by Stefan Feulner on November 29th, 2022 | 13:32 CET

    Nvidia, Meta Materials, SFC Energy - Strong signs

    • Technology
    • Investments
    • nanotechnology

    After turbulent months on the technology stock markets with high markdowns, a bottoming out is taking place across the board. While many companies are reporting better-than-expected figures, investors are also buying oversold companies whose quarterly figures were below analysts' consensus. Due to the still high fluctuation range, high trading profits can be expected.

    Read